{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T14:56:02Z","timestamp":1758812162286},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008530","name":"EC | European Regional Development Fund","doi-asserted-by":"publisher","award":["GINOP-2.3.2-15-2016-00008"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00008"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1038\/s41429-019-0164-1","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T09:04:12Z","timestamp":1552640652000},"page":"524-534","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["New semisynthetic teicoplanin derivatives have comparable in vitro activity to that of oritavancin against clinical isolates of VRE"],"prefix":"10.1038","volume":"72","author":[{"given":"Zsolt","family":"Sz\u0171cs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eszter","family":"Ostorh\u00e1zi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1t\u00e9","family":"Kics\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lajos","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anik\u00f3","family":"Borb\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e1l","family":"Herczegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,15]]},"reference":[{"issue":"Supplement_1","key":"164_CR1","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1086\/491709","volume":"42","author":"D Levine","year":"2006","unstructured":"Levine D. Vancomycin: a history. Clin Infect Dis. 2006;42(Supplement_1):S5\u2013S12.","journal-title":"Clin Infect Dis"},{"key":"164_CR2","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1128\/AAC.41.10.2165","volume":"41","author":"F Biavasco","year":"1997","unstructured":"Biavasco F, et al. In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide. Antimicrob Agents Chemother. 1997;41:2165\u201372.","journal-title":"Antimicrob Agents Chemother"},{"key":"164_CR3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/ja.2006.77","volume":"59","author":"F Sztaricskai","year":"2006","unstructured":"Sztaricskai F, et al. A new series of glycopeptide antibiotics incorporating a squaric acid Moiety. J Antibiot. 2006;59:564\u201382.","journal-title":"J Antibiot"},{"key":"164_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ejmech.2012.10.030","volume":"58","author":"A Sipos","year":"2012","unstructured":"Sipos A, et al. Synthesis of fluorescent ristocetin aglycon derivatives with remarkable antibacterial and antiviral activities. Eur J Med Chem. 2012;58:361\u20137.","journal-title":"Eur J Med Chem"},{"key":"164_CR5","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.1021\/jm900950d","volume":"52","author":"G Pinte\u0301r","year":"2009","unstructured":"Pinte\u0301r G, et al. Diazo transfer\u2212click reaction route to new, lipophilic teicoplanin and ristocetin aglycon derivatives with high antibacterial and anti-influenza virus activity: an aggregation and receptor binding study. J Med Chem. 2009;52:6053\u201361.","journal-title":"J Med Chem"},{"key":"164_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ja.2016.80","volume":"70","author":"Z Sz\u0171cs","year":"2016","unstructured":"Sz\u0171cs Z, et al. Synthesis and biological evaluation of lipophilic teicoplanin pseudoaglycon derivatives containing a substituted triazole function. J Antibiot. 2016;70:152\u20137.","journal-title":"J Antibiot"},{"key":"164_CR7","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/ja.2017.2","volume":"70","author":"Z Sz\u0171cs","year":"2017","unstructured":"Sz\u0171cs Z, et al. Lipophilic teicoplanin pseudoaglycon derivatives are active against vancomycin- and teicoplanin-resistant enterococci. J Antibiot. 2017;70:664\u201370.","journal-title":"J Antibiot"},{"key":"164_CR8","doi-asserted-by":"publisher","first-page":"988","DOI":"10.7164\/antibiotics.37.988","volume":"37","author":"A Malabarba","year":"1984","unstructured":"Malabarba A, et al. Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. VI. Chemical degradation: physico-chemical and biological properties of acid hydrolysis products. J Antibiot. 1984;37:988\u201399.","journal-title":"J Antibiot"},{"key":"164_CR9","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.7164\/antibiotics.43.1107","volume":"43","author":"A Malabarba","year":"1990","unstructured":"Malabarba A, et al. N\n15-alkyl and N\n15, N\n15-dialkyl derivatives of teicoplanin antibiotics. J Antibiot. 1990;43:1107\u201321.","journal-title":"J Antibiot"},{"key":"164_CR10","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.7164\/antibiotics.40.1572","volume":"40","author":"A Malabarba","year":"1987","unstructured":"Malabarba A, Trani A, Ferrari P, Pallanza R, Cavalleri B. Synthesis and biological activity of some esters of the N-acetylglucosaminyl aglycone and of the aglycone of teicoplanin. J Antibiot. 1987;40:1572\u201387.","journal-title":"J Antibiot"},{"key":"164_CR11","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.7164\/antibiotics.42.1800","volume":"42","author":"A Malabarba","year":"1989","unstructured":"Malabarba A, Ferrari P, Cietto G, Pallanza R, Berti M. Synthesis and biological activity of N\n63-carboxypeptides of teicoplanin and teicoplanin aglycone. J Antibiot. 1989;42:1800\u201316.","journal-title":"J Antibiot"},{"key":"164_CR12","doi-asserted-by":"publisher","first-page":"668","DOI":"10.7164\/antibiotics.46.668","volume":"46","author":"A Malabarba","year":"1993","unstructured":"Malabarba A, et al. N\n63-carboxamides of N\n15-alkyl and N\n15, N\n15-dialkyl derivatives of teicoplanin and deglucoteicoplanin. J Antibiot. 1993;46:668\u201375.","journal-title":"J Antibiot"},{"key":"164_CR13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.7164\/antibiotics.46.661","volume":"46","author":"A Malabarba","year":"1993","unstructured":"Malabarba A, Ciabatti R, Scotti R, Goldstein B. Octapeptide derivatives of teicoplanin antibiotics. J Antibiot. 1993;46:661\u20137.","journal-title":"J Antibiot"},{"key":"164_CR14","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.7164\/antibiotics.42.1268","volume":"42","author":"A Trani","year":"1989","unstructured":"Trani A, Ferrari P, Pallanza R, Ciabatti R. Thioureas and isothiouronium salts of the aglycone of teicoplanin. I. Synthesis and biological activity. J Antibiot. 1989;42:1268\u201375.","journal-title":"J Antibiot"},{"key":"164_CR15","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.7164\/antibiotics.47.1493","volume":"47","author":"A Malabarba","year":"1994","unstructured":"Malabarba A, et al. Amides of de-acetylglucosaminyl-deoxy teicoplanin active against highly glycopeptide-resistant enterococci. Synthesis and antibacterial activity. J Antibiot. 1994;47:1493\u2013506.","journal-title":"J Antibiot"},{"key":"164_CR16","doi-asserted-by":"publisher","first-page":"869","DOI":"10.7164\/antibiotics.48.869","volume":"48","author":"A Malabarba","year":"1995","unstructured":"Malabarba A, et al. New Semisynthetic Glycopeptides MDL 63,246 and MDL 63,042, and other amide derivatives of antibiotic A-40,926 active against highly glycopeptide-resistant VanA enterococci. J Antibiot. 1995;48:869\u201383.","journal-title":"J Antibiot"},{"key":"164_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.7164\/antibiotics.37.615","volume":"37","author":"A Borghi","year":"1984","unstructured":"Borghi A, et al. Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. IV. Separation and characterization of the components of teichomycin (teicoplanin). J Antibiot. 1984;37:615\u201320.","journal-title":"J Antibiot"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41429-019-0164-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-019-0164-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-019-0164-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:31:53Z","timestamp":1684618313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-019-0164-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,15]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["164"],"URL":"https:\/\/doi.org\/10.1038\/s41429-019-0164-1","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,15]]},"assertion":[{"value":"8 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}